Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
sábado, octubre 24
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Tenet Healthcare Corp
THC
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$268.45
-2.18
-0.81%
Últ. Act.: Oct 23, 4:00 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Ganancias:
Beneficios de Q3 2026 dentro de 6 días de ahora en jue oct 29th, antes de la apertura del mercado
Conferencia telefónica:
Conferencia telefónica programada para dentro de 6 días a las 10:00 a. m.
Haz clic para ver el webcast
Tenet Healthcare Financials
Tenet Healthcare (THC) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Tenet's Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade
Tenet Healthcare lifted its 2026 outlook after beating Q2 estimates, citing hospital growth, expense control and M&A momentum.
Vandana Singh
PRO
Tenet Healthcare Raises FY2026 GAAP EPS Guidance from $22.94-$32.64 to $34.57-$36.43 vs $24.76 Est
Tenet Healthcare (NYSE:THC) raises FY2026 GAAP EPS guidance from $22.94-$32.64 to $34.57-$36.43 vs $24.76 analyst estimate..
Benzinga Newsdesk
PRO
Tenet Healthcare Raises FY2026 Adj EPS Guidance from $16.38-$18.68 to $20.30-$21.69 vs $17.88 Est; Raises FY2026 Sales Guidance from $21.500B-$22.300B to $21.900B-$22.500B vs $21.996B Est
Tenet Healthcare (NYSE:THC) raises FY2026 Adj EPS guidance from $16.38-$18.68 to $20.30-$21.69 vs $17.88 analyst estimate. Raises FY2026 sales outlook from $21.500 billion-$22.300 billion to $21.900 billion-$22.500
Benzinga Newsdesk
PRO
Tenet Healthcare Q2 Adj. EPS $6.12 Beats $4.23 Estimate, Sales $5.628B Beat $5.430B Estimate
Tenet Healthcare (NYSE:THC) reported quarterly earnings of $6.12 per share which beat the analyst consensus estimate of $4.23 by 44.68 percent. This is a 52.24 percent increase over earnings of $4.02 per share from the
Benzinga Newsdesk
Tenet Healthcare Blames Admissions Mix For Soft Q1 Sales
Tenet Healthcare posts Q1 earnings beat but revenue miss as payer mix shifts and external disruptions weigh on performance.
Vandana Singh
Earnings Scheduled For April 30, 2026
Benzinga Insights
